Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1423053 MIAMI, FL
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$0
-$273,431 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Derivatives in SLS

reported options exposure · as of Jun 30, 2026
CallValue
$64,157,292
CallShares
4,346,700
PutValue
$33,333,984
PutShares
2,258,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in SLS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,333,984 2,258,400
2026-06-30 $64,157,292 4,346,700
2026-03-31 $1,902,654 449,800
2026-03-31 $18,477,486 4,368,200
2026-03-31 $273,431 64,641
2025-12-31 $7,138,872 1,893,600
2025-12-31 $364,559 96,700
2025-09-30 $858,291 533,100
2025-09-30 $312,914 194,357
2025-09-30 $105,294 65,400
2025-06-30 $72,270 33,000
2025-06-30 $186,134 84,993
2025-06-30 $1,007,181 459,900
2025-03-31 $285,768 264,600
2025-03-31 $28,404 26,300
2025-03-31 $377,465 349,505
2024-12-31 $29,848 28,700
2024-12-31 $235,456 226,400
2024-12-31 $504,729 485,317
2024-09-30 $203,500 162,800
2024-09-30 $59,148 47,319
2024-09-30 $93,375 74,700
2024-06-30 $176,358 148,200
2024-06-30 $13,923 11,700
2024-03-31 $148,874 147,400
2024-03-31 $19,915 19,718
2024-03-31 $1,616 1,600
2023-12-31 $16,218 15,300
2023-12-31 $281,960 266,000
2023-09-30 $418,036 254,900
2023-09-30 $28,044 17,100
2023-06-30 $39,250 25,000
2023-06-30 $4,964 3,162
2023-06-30 $431,279 274,700
2023-03-31 $68,497 47,900
2023-03-31 $375,518 262,600
2022-12-31 $779,744 330,400
2022-12-31 $7,965 3,375
2022-12-31 $32,332 13,700
2022-09-30 $21,614 10,700
2022-09-30 $217,271 107,560
2022-09-30 $763,560 378,000
2022-06-30 $24,084 10,800
2022-06-30 $83,934 37,639
2022-06-30 $900,697 403,900
2022-03-31 $1,059,448 158,600
2022-03-31 $89,311 13,370
2022-03-31 $142,952 21,400
2021-12-31 $1,478,169 267,300
2021-12-31 $225,861 40,843